Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Alissa Interpret serves as a comprehensive genomic data interpretation tool designed for enhancing clinical decision-making. It boosts your efficiency, reduces turnaround times, and ensures adherence to regulatory standards through its versatile CGH and NGS tertiary analysis platform dedicated to variant interpretation and reporting. When combined with Agilent’s top-tier SureSelect NGS reagents, the user-friendly secondary NGS analysis tool Alissa Reporter, Magnis walkaway automation, and TapeStation QC, Alissa Interpret achieves peak operational effectiveness for an efficient NGS data analysis process. Access to both external and internal curated variant knowledgebases is readily available, while the automated variant interpretation system speeds up CGH and NGS tertiary analysis. This single platform accommodates various genomic elements such as SNVs, InDels, CNVs, LOH, and fusions, and seamlessly integrates with your LIMS to eliminate any genomic data analysis delays. Furthermore, it fosters collaboration among peers, enabling the sharing of insights and ultimately enhancing diagnostic accuracy. By leveraging Alissa Interpret, laboratories can not only streamline their workflows but also elevate their overall diagnostic performance.
Description
AlphaGenome 2 is an advanced AI framework and research platform dedicated to examining the impact of DNA sequences on gene regulation and associated molecular mechanisms. By inputting DNA sequences, it can forecast various molecular characteristics, thereby assisting researchers in exploring regulatory functions, gene expression patterns, splicing, chromatin accessibility, and a range of other genomic indicators. This tool is specifically tailored for scientists focused on understanding gene functions, the repercussions of genetic variants, and the biology of diseases, catering to both academic and noncommercial research entities. Accessible via an online API, it provides developer tools that facilitate the submission of sequences and the retrieval of predictions that support computational analyses. In turn, researchers can leverage these predictions to prioritize their hypotheses and guide subsequent experiments effectively. It is crucial to note that AlphaGenome 2 is strictly meant for research applications and has not undergone validation or received approval for clinical or diagnostic use, ensuring that users are aware of its intended scope and limitations. This emphasis on research utility highlights the importance of responsible application in scientific endeavors.
API Access
Has API
No
API Access
Has API
Yes
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
The AlphaGenome API is free of charge for noncommercial use. Commercial research access is in private preview.
Free Trial
No
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Agilent Technologies
Founded
1999
Country
United States
Website
www.agilent.com/product/next-generation-sequencing/ngs-data-analysis-interpretation/alissa-interpret-4301560
Vendor Details
Company Name
Google DeepMind
Founded
2010
Country
United Kingdom
Website
deepmind.google/science/alphagenome/